Excitingly, ASOs designed to block the inclusion of the BRD9 poison exon was sufficient to rescue mis-splicing, increase protein levels, and suppress tumor growth in both UVM cells and mice xenografted with UVM cells. This evidence concerns the gene BRD9 and neoplasm.